Proffitt & Goodson Inc Moderna, Inc. Transaction History
Proffitt & Goodson Inc
- $605 Million
- Q1 2025
A detailed history of Proffitt & Goodson Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Proffitt & Goodson Inc holds 150 shares of MRNA stock, worth $4,281. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150Holding current value
$4,281% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding MRNA
# of Institutions
917Shares Held
253MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.15 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.11 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$730 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$502 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$209 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $11.2B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...